Corcept Therapeutics | CORT - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Alaunos Therapeutics USD 1.07M 215K 2023-06
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Ardelyx USD 5.6M 160K 2026-03
Aurora Cannabis CAD 230K 1.88M 2026-03
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Bristol-Myers Squibb USD 411M 21M 2026-03
Canopy Growth CAD 12.31M 4.97M 2026-03
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Esperion Therapeutics USD 22.64M 585K 2025-12
J&J USD 43M 25M 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Merck USD 479M 67M 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 343M 39M 2026-03
Novartis USD 281M 8M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.7M 193K 2026-03
Pfizer USD 671M 40M 2026-03
Supernus Pharmaceuticals USD 910K 278K 2023-06
TG Therapeutics USD 7.67M 1.13M 2026-03